Eli Lilly’s Alopecia Drug Shows Strong Phase 3 Results; Senator Rubio Addresses Gaza Future and UNRWA
Key Takeaways Eli Lilly's (LLY) Baricitinib (Olumiant) demonstrated significant scalp hair regrowth in over 50% of adolescents with severe alopecia […]
